The company's pipeline of mRNA-based vaccine candidates, for infectious diseases ranging from RSV to influenza, all the way to a type of cancer vaccine, is underrated, and could yield five new marketed products by 2026.
Unlike traditional vaccines, ones based on mRNA tech use messenger RNA, which provide the body instructions to code for and create certain types of proteins, essentially turn your own cells into mini drug-making factories that produce an immune response against the specific biological adversary you're fighting.
[
Collection
]
[
|
...
]